Levitra Related Published Studies
Well-designed clinical trials related to Levitra (Vardenafil)
Efficacy and safety of vardenafil for the treatment of erectile dysfunction in men with metabolic syndrome: results of a randomized, placebo-controlled trial. [2011.10]
The use of beat-to-beat electrocardiogram analysis to distinguish QT/QTc interval changes caused by moxifloxacin from those caused by vardenafil. [2011.09]
Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study. [2011.06.15]
[Small-dose vardenafil restores erectile function after penile surgery]. [2011.04]
Comparison of the first intake of vardenafil and tadalafil in patients with diabetic neuropathy and diabetic erectile dysfunction. [2011.03]
Effects of sildenafil and vardenafil treatments on sleep quality and depression in hemodialysis patients with erectile dysfunction. [2011.01]
Pharmacokinetics of a new orodispersible tablet formulation of vardenafil: results of three clinical trials. [2011]
Effects of sildenafil and vardenafil on erectile dysfunction and health-related quality of life in haemodialysis patients: a prospective randomized crossover study. [2010.11]
Efficacy of phosphodiesterase type 5 inhibitor treatment in men with erectile dysfunction and dyslipidemia: a post hoc analysis of the vardenafil statin study. [2010.05]
The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. [2010.04]
Vardenafil can improve continence recovery after bilateral nerve sparing prostatectomy: results of a randomized, double blind, placebo-controlled pilot study. [2010.01]
Vardenafil improves erectile function in men with erectile dysfunction and
associated underlying conditions, irrespective of the use of concomitant
medications. [2010]
Vardenafil allows successful intercourse initiated rapidly after dosing in Japanese patients with diabetes mellitus and erectile dysfunction. [2009.10]
Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. [2009.07]
Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: a randomised, prospective and crossover study. [2009.06]
Evaluation of vardenafil for the treatment of subjective tinnitus: a controlled pilot study. [2009.02.17]
Does on-demand vardenafil improve erectile function recovery after radical prostatectomy? [2009.01]
Effect of vardenafil on blood pressure profile of patients with erectile dysfunction concomitantly treated with doxazosin gastrointestinal therapeutic system for benign prostatic hyperplasia. [2008.09]
Effect of Vardenafil on Blood Pressure Profile of Patients With Erectile Dysfunction Concomitantly Treated With Doxazosin Gastrointestinal Therapeutic System for Benign Prostatic Hyperplasia. [2008.07.16]
A double-blind, placebo-controlled, randomized clinical study of the effects of vardenafil on human nasal patency. [2008.05]
Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury. [2008.04.01]
Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury. [2008.04.01]
Daily vardenafil for 6 months has no detrimental effects on semen characteristics or reproductive hormones in men with normal baseline levels. [2008.03]
Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study. [2007.11]
Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data. [2007.10]
The Treatment Satisfaction Scale (TSS) is a sensitive measure of treatment effectiveness for both patients and partners: results of a randomized controlled trial with vardenafil. [2007.07]
Improvement in erectile function on vardenafil treatment correlates with treatment satisfaction in both patients and their partners. [2007.07]
Improvement in erectile function on vardenafil treatment correlates with treatment satisfaction in both patients and their partners. [2007.05.04]
The efficacy and safety of vardenafil in East Asian men with erectile dysfunction. [2007.05]
Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): a randomized, double-blind, placebo-controlled trial in PDE5 inhibitor-naive men with ED and their partners. [2006.11]
Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction. [2006.09]
The effect of vardenafil on endothelial function of brachial and cavernous arteries. [2006.09]
Efficacy and safety of vardenafil in renal transplant recipients with erectile dysfunction. [2006.06]
Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives. [2005.11]
Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial. [2005.11]
Sustained efficacy and safety of vardenafil for treatment of erectile dysfunction: a randomized, double-blind, placebo-controlled study. [2005.10]
Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil. [2005.09]
Vardenafil in patients with erectile dysfunction: achieving treatment optimization. [2005.09]
Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis. [2005.06]
Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. [2005.06]
[Efficacy and tolerability of vardenafil within the time window of 6 hours after administration and beyond. Results of a clinical study carried out in 233 urological offices] [2005.04.07]
[Efficacy and safety of oral vardenafil in the treatment of erectile dysfunction] [2004.12]
Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial. [2004.12]
Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia. [2004.11]
Vardenafil improves patient satisfaction with erection hardness, orgasmic function, and overall sexual experience, while improving quality of life in men with erectile dysfunction. [2004.09]
Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: a randomized, double-blind, placebo-controlled trial. [2004.09]
Safety and efficacy of vardenafil in patients with erectile dysfunction: result of a bridging study in Japan. [2004.07]
Evaluation of vardenafil and sildenafil on cardiac repolarization. [2004.06.01]
The efficacy and safety of flexible-dose vardenafil (levitra) in a broad population of European men. [2004.05]
Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction. [2004.03]
Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. [2003.10]
Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups. [2003.09]
Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial. [2003.04]
Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction. [2003.03]
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. [2003.03]
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease. [2002.12.04]
Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose. [2001.08]
The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. [2001.08]
Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study. [2001.02]
Well-designed clinical trials possibly related to Levitra (Vardenafil)
The effect of simvastatin in penile erection: a randomized, double-blind, placebo-controlled clinical trial (Simvastatin treatment for erectile dysfunction-STED TRIAL). [2011.11]
The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study. [2011.04]
The effects of phosphodiesterase type 5 inhibitors on penile rigidity variables during a period with no sexual stimulation: a laboratory setting double-blind study. [2011.01]
Stopwatch-assessed duration of erection: a new measure of the efficacy of
erectile dysfunction treatments. [2011]
Effects of phosphodiesterase-5 inhibitors on Leydig cell secretory function in oligoasthenospermic infertile men: a randomized trial. [2010.10]
The efficacy and safety of testosterone undecanoate (Nebido((R))) in testosterone deficiency syndrome in Korean: a multicenter prospective study. [2010.06]
Validation of stopwatch measurements of erection duration against responses to the sexual encounter profile and international index of erectile Function in patients treated with a phosphodiesterase type 5 inhibitor. [2010.03]
Platelet cyclic guanosine monophosphate as a biomarker of phosphodiesterase type 5 inhibitor efficacy in the treatment of erectile dysfunction: a randomized placebo-controlled study. [2009.12]
Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. [2009.11.03]
Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis. [2009.10.19]
Prospective pharmacologic therapies for the overactive bladder. [2009.06]
The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction. [2009.03]
Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence. [2008.05]
Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence. [2008.01.10]
Responsiveness and minimum important differences for the erection quality scale. [2007.11]
Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response. [2005.04]
Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men. [2004.11]
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. [2004.10.06]
Other research related to Levitra (Vardenafil)
Response to on-demand vardenafil was improved by its daily usage in hypertensive
men. [2012]
A pilot study to evaluate the effects of vardenafil on sexual distress in men
with obesity. [2012]
Time to onset of action of vardenafil: a retrospective analysis of the pivotal trials for the orodispersible and film-coated tablet formulations. [2011.10]
Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: a randomized, double-blind, placebo-controlled study. [2011.10]
Beneficial Effect of Vardenafil on Aortic Stiffness and Wave Reflections. [2011.09.27]
Brachial flow-mediated dilation correlates with vardenafil response in hypertensive men with vasculogenic erectile dysfunction. [2011.08]
Results of vardenafil mediated power Doppler ultrasound, contrast enhanced ultrasound and systematic random biopsies to detect prostate cancer. [2011.06]
A spontaneous, double-blind, double-dummy cross-over study on the effects of daily vardenafil on arterial stiffness in patients with vasculogenic erectile dysfunction. [2011.05.05]
Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat: preliminary findings. [2011.04]
Combination of testosterone and vardenafil increases female sexual functioning in sub-primed rats. [2011.04]
Chronic vardenafil treatment improves erectile function via structural maintenance of penile corpora cavernosa in rats with acute arteriogenic erectile dysfunction. [2011.03]
Incremental cost-effectiveness of various monthly doses of vardenafil. [2011.01]
Effects of vardenafil on testicular torsion/detorsion damage: an experimental study in pigs. [2011]
The use of beat-to-beat electrocardiogram analysis to distinguish QT/QTc interval
changes caused by moxifloxacin from those caused by vardenafil. [2011]
[Small-dose vardenafil restores erectile function after penile surgery]. [Article in Chinese] [2011]
Effects of sildenafil and vardenafil treatments on sleep quality and depression
in hemodialysis patients with erectile dysfunction. [2011]
[Clinical efficacy of vardenafil on ED patients with kidney-yang or -yin deficiency or liver-qi stasis]. [2010.09]
Efficacy and Safety of an Orodispersible Vardenafil Formulation for the Treatment of Erectile Dysfunction in Elderly Men and Those with Underlying Conditions: An Integrated Analysis of Two Pivotal Trials. [2010.08.30]
Effects of sildenafil and vardenafil on erectile dysfunction and health-related quality of life in haemodialysis patients: a prospective randomized crossover study. [2010.05.02]
The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. [2010.04]
Pharmacotherapy for erectile dysfunction. [2010.01]
Effects of sildenafil and vardenafil on erectile dysfunction and health-related
quality of life in haemodialysis patients: a prospective randomized crossover
study. [2010]
Efficacy of phosphodiesterase type 5 inhibitor treatment in men with erectile
dysfunction and dyslipidemia: a post hoc analysis of the vardenafil statin study. [2010]
Vardenafil can improve continence recovery after bilateral nerve sparing
prostatectomy: results of a randomized, double blind, placebo-controlled pilot
study. [2010]
|
